The overall purpose of this proposed NEI K12, Michigan Vision Clinician-Scientist Development Program is to increase the number and effectiveness of clinician-scientists in ophthalmology and vision sciences through interdisciplinary, interdepartmental faculty development bridging the transition to research independence. The specific objective is to provide a superb, new mentored clinician-scientist career development program at the University of Michigan, in a highly collegial environment that includes an extensive array of didactic opportunities and core facilities. This proposal is based on the recent expansion of the faculty and laboratory and clinical research infrastructure, extensive interdisciplinary research opportunities within the University of Michigan, and the need to advance clinician-scientists into successful research careers. The University of Michigan excels in many vision-sciences areas that complement current NEI K12 awards, notably retinal stem cells and regeneration, diabetic retinopathy, epidemiology and biostatistics, and thyroid eye disease. The Program is designed to ensure success of clinician-scientists in ophthalmology, visual sciences, and health services research by providing protected research time and strong examples of bench and bedside research. The Program includes mentors who will foster the careers of women and minorities. The Michigan Vision Clinician-Scientist Development Program will allow premier scholars to create tailored research career development plans that connect their basic and clinical research interests with medical or surgical specialties. The University of Michigan is uniquely poised to fill a niche by developing novel research directions to deliver new advances to persons suffering from eye disease. The following specific aims describe two paths that feature laboratory or clinic-based studies from broad areas of biomedical research.
Specific Aim 1 will provide scholars in the laboratory science path with the knowledge and technologies needed to study fundamental mechanisms and pathogenesis of vision-threatening diseases.
Specific Aim 2 will provide scholars in the clinical science path with leading-edge knowledge and technologies to conduct patient-based investigations. The two paths in Michigan Vision Clinician-Scientist Development Program converge to produce superbly trained clinician-scientists who will transition to independent funding and long-term research career success. Our proposal demonstrates the exceptional enthusiasm, commitment and environment for this distinctive mentored training program at the University of Michigan that will bring new research leaders to American ophthalmology and vision research.
The proposed NEI K12, Michigan Vision Clinician-Scientist Development Program seeks to increase the number and effectiveness of clinician-scientists in ophthalmology and vision sciences through interdisciplinary, interdepartmental faculty development bridging the transition to research independence. The Program fills a niche in mentored research involving retinal stem cells and regeneration, diabetic retinopathy, epidemiology and biostatistics, and thyroid eye disease.
|Rao, Rajesh C; Choudhry, Netan (2016) Cystoid macular edema associated with chemotherapy. CMAJ 188:216|
|Zhang, Hui; Gayen, Srimonta; Xiong, Jie et al. (2016) MLL1 Inhibition Reprograms Epiblast Stem Cells to Naive Pluripotency. Cell Stem Cell 18:481-94|
|Choudhry, Netan; Rao, Rajesh C (2016) ENHANCED DEPTH IMAGING FEATURES OF A CHOROIDAL MACROVESSEL. Retin Cases Brief Rep 10:18-21|
|Avedschmidt, Sarah E; Stagner, Anna M; Eagle Jr, Ralph C et al. (2016) The Targetable Epigenetic Tumor Protein EZH2 is Enriched in Intraocular Medulloepithelioma. Invest Ophthalmol Vis Sci 57:6242-6246|
|Choudhry, Netan; Golding, John; Manry, Matthew W et al. (2016) Ultra-Widefield Steering-Based Spectral-Domain Optical Coherence Tomography Imaging of the Retinal Periphery. Ophthalmology 123:1368-74|
|Cani, Andi K; Soliman, Moaaz; Hovelson, Daniel H et al. (2016) Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies. Mod Pathol 29:685-97|
|Yan, Naihong; Cheng, Lin; Cho, Kinsang et al. (2016) Postnatal onset of retinal degeneration by loss of embryonic Ezh2 repression of Six1. Sci Rep 6:33887|
|Killeen, Olivia J; MacKenzie, Chamisa; Heisler, Michele et al. (2016) User-centered Design of the eyeGuide: A Tailored Glaucoma Behavior Change Program. J Glaucoma 25:815-821|
|Newman-Casey, Paula A; Shtein, Roni M; Coleman, Anne L et al. (2016) Why Patients With Glaucoma Lose Vision: The Patient Perspective. J Glaucoma 25:e668-75|
|Rao, Rajesh C; Chan, May P; Andrews, Christopher A et al. (2016) EZH2, Proliferation Rate, and Aggressive Tumor Subtypes in Cutaneous Basal Cell Carcinoma. JAMA Oncol 2:962-3|
Showing the most recent 10 out of 36 publications